236 related articles for article (PubMed ID: 22771734)
1. Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system.
Park CW; Son DD; Kim JY; Oh TO; Ha JM; Rhee YS; Park ES
Int J Pharm; 2012 Oct; 436(1-2):32-40. PubMed ID: 22771734
[TBL] [Abstract][Full Text] [Related]
2. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
Ameen D; Michniak-Kohn B
Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
[TBL] [Abstract][Full Text] [Related]
3. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
[TBL] [Abstract][Full Text] [Related]
4. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
[TBL] [Abstract][Full Text] [Related]
5. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
[TBL] [Abstract][Full Text] [Related]
6. Development of a drug-in-adhesive patch combining ion pair and chemical enhancer strategy for transdermal delivery of zaltoprofen: pharmacokinetic, pharmacodynamic and in vitro/in vivo correlation evaluation.
Cui H; Quan P; Zhou Z; Fang L
Drug Deliv; 2016 Nov; 23(9):3461-3470. PubMed ID: 27257038
[TBL] [Abstract][Full Text] [Related]
7. Development of drug-in-adhesive transdermal patch for α-asarone and in vivo pharmacokinetics and efficacy evaluation.
Hu Y; Wu YY; Xia XJ; Wu Z; Liang WQ; Gao JQ
Drug Deliv; 2011 Jan; 18(1):84-9. PubMed ID: 20939674
[TBL] [Abstract][Full Text] [Related]
8. Drug in Adhesive Patch of Zolmitriptan: Formulation and In vitro /In vivo Correlation.
Liu C; Fang L
AAPS PharmSciTech; 2015 Dec; 16(6):1245-53. PubMed ID: 25771739
[TBL] [Abstract][Full Text] [Related]
9. Drug in adhesive patch of palonosetron: Effect of pressure sensitive adhesive on drug skin permeation and in vitro-in vivo correlation.
Liu C; Hui M; Quan P; Fang L
Int J Pharm; 2016 Sep; 511(2):1088-97. PubMed ID: 27521703
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of galantamine gel as drug reservoir in transdermal patch delivery system.
Fong Yen W; Basri M; Ahmad M; Ismail M
ScientificWorldJournal; 2015; 2015():495271. PubMed ID: 25853145
[TBL] [Abstract][Full Text] [Related]
11. Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.
Jiang Q; Wang J; Ma P; Liu C; Sun M; Sun Y; He Z
Drug Deliv Transl Res; 2018 Feb; 8(1):64-72. PubMed ID: 29181834
[TBL] [Abstract][Full Text] [Related]
12. In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo.
Leonard AK; Sileno AP; Brandt GC; Foerder CA; Quay SC; Costantino HR
Int J Pharm; 2007 Apr; 335(1-2):138-146. PubMed ID: 17174048
[TBL] [Abstract][Full Text] [Related]
13. Formulation and biopharmaceutical evaluation of a transdermal patch containing aceclofenac.
Rhee YS; Nguyen T; Park ES; Chi SC
Arch Pharm Res; 2013 May; 36(5):602-7. PubMed ID: 23475315
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel high-concentration galantamine formulation suitable for intranasal delivery.
Leonard AK; Sileno AP; MacEvilly C; Foerder CA; Quay SC; Costantino HR
J Pharm Sci; 2005 Aug; 94(8):1736-46. PubMed ID: 15986464
[TBL] [Abstract][Full Text] [Related]
15. Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole.
Li L; Fang L; Xu X; Liu Y; Sun Y; He Z
Biopharm Drug Dispos; 2010 Mar; 31(2-3):138-49. PubMed ID: 20140970
[TBL] [Abstract][Full Text] [Related]
16. Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: improved transdermal absorption and evaluation of efficacy and safety.
Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
Eur J Pharm Sci; 2014 Feb; 52():86-94. PubMed ID: 24215737
[TBL] [Abstract][Full Text] [Related]
17. Novel biomaterial for transdermal application: in vitro and in vivo characterization.
Mundada AS; Avari JG
Drug Deliv; 2011 Aug; 18(6):424-31. PubMed ID: 21554152
[TBL] [Abstract][Full Text] [Related]
18. Development of a Prolonged-Release Pramipexole Transdermal Patch: In Vitro and In Vivo Evaluation.
Pu T; Li X; Sun Y; Ding X; Pan Y; Wang Q
AAPS PharmSciTech; 2017 Apr; 18(3):738-748. PubMed ID: 27245330
[TBL] [Abstract][Full Text] [Related]
19. Formulation optimization of a drug in adhesive transdermal analgesic patch.
Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
[TBL] [Abstract][Full Text] [Related]
20. Development of drug-in-adhesive patch formulations for transdermal delivery of fluoxetine: In vitro and in vivo evaluations.
Jung E; Lee EY; Choi HK; Ban SJ; Choi SH; Kim JS; Yoon IS; Kim DD
Int J Pharm; 2015 Jun; 487(1-2):49-55. PubMed ID: 25863117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
